Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Nature
|
January 17, 2020
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
Emina Torlakovic, Hyun J Lim, Julien Adam, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
International Journal of Cancer
|
March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years
Clémence Basse, Antoine Italiano, Nicolas Penel, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Cancer Discovery
|
August 26, 2022
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
John A Grout, Philemon Sirven, Andrew M Leader, et al.
Cancer
|
September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
JHLT Open
|
December 1, 2025
Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey
Fiorella Calabrese, David M Hwang, Francesca Lunardi, et al.
Oncoimmunology
|
February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Nature
|
January 17, 2020
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
Emina Torlakovic, Hyun J Lim, Julien Adam, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
International Journal of Cancer
|
March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years
Clémence Basse, Antoine Italiano, Nicolas Penel, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Cancer Discovery
|
August 26, 2022
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
John A Grout, Philemon Sirven, Andrew M Leader, et al.
Cancer
|
September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
JHLT Open
|
December 1, 2025
Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey
Fiorella Calabrese, David M Hwang, Francesca Lunardi, et al.
Oncoimmunology
|
February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
Page
of 16